Mirova Portfolio holdings
Mirova is a Paris-based asset manager devoted to sustainable investing and an affiliate of Natixis Investment Managers. Philippe Zaouati founded it in 2012 as a department of Natixis Asset Management (later renamed Ostrum Asset Management), and in 2014 it became a direct affiliate of Natixis Investment Managers. Mirova aims to build every portfolio to fit a climate path below 2°C, and its Althelia funds invest in the sustainable management of land and marine resources. It bought SunFunder, a Nairobi-based specialist in clean energy and climate investment in emerging markets, in 2022, and in 2020 became a mission-driven company under French law.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGCO
AGCO
|
+$4.87M |
| 2 |
NVIDIA
NVDA
|
+$3.34M |
| 3 |
Sunrun
RUN
|
+$3.02M |
| 4 |
Waste Management
WM
|
+$3M |
| 5 |
S&P Global
SPGI
|
+$2.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$1.84M |
| 2 |
Dow Inc
DOW
|
+$1.6M |
| 3 |
First Solar
FSLR
|
+$1.57M |
| 4 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$1.56M |
| 5 |
Intel
INTC
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.71% |
| 2 | Technology | 23.64% |
| 3 | Materials | 14.01% |
| 4 | Financials | 7.16% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$259B
| $175M | 24.9% |
322,549
+257
| +0.1% | +$141K |
2018 Q4
14 quarters
|
|
2
Ecolab
ECL
$86.7B
| $94.3M | 13.41% |
613,466
+3,128
| +0.5% | +$519K |
2018 Q4
14 quarters
|
|
|
3
Sunrun
RUN
$2.09B
| $48M | 6.82% |
2,053,868
+125,717
| +7% | +$3.02M |
2019 Q4
10 quarters
|
|
4
Microsoft
MSFT
$3.89T
| $21.2M | 3.01% |
82,545
-211
| -0.3% | -$57.3K |
2018 Q4
14 quarters
|
|
5
CGI
GIB
$16.7B
| $20.5M | 2.91% |
257,343
-6,152
| -2% | -$497K |
2018 Q4
14 quarters
|
|
6
Mastercard
MA
$576B
| $16.9M | 2.4% |
53,439
+1,798
| +3% | +$619K |
2018 Q4
14 quarters
|
|
7
Eli Lilly
LLY
$1.29T
| $14.4M | 2.05% |
44,386
+2,584
| +6% | +$776K |
2018 Q4
14 quarters
|
|
|
8
NVIDIA
NVDA
$3.93T
| $11.2M | 1.59% |
737,860
+176,990
| +32% | +$3.34M |
2018 Q4
14 quarters
|
|
9
American Water Works
AWK
$29.8B
| $10.4M | 1.48% |
69,785
+3,588
| +5% | +$547K |
2018 Q4
14 quarters
|
|
10
Adobe
ADBE
$94.6B
| $10.2M | 1.45% |
27,958
+6,427
| +30% | +$2.62M |
2018 Q4
14 quarters
|
|
|
11
Waste Management
WM
$97B
| $9.02M | 1.28% |
58,996
+19,128
| +48% | +$3M |
2019 Q1
13 quarters
|
|
12
Visa
V
$794B
| $8.98M | 1.28% |
45,629
+1,742
| +4% | +$360K |
2018 Q4
14 quarters
|
|
13
NextEra Energy
NEE
$179B
| $8.62M | 1.22% |
111,233
+2,578
| +2% | +$196K |
2018 Q4
14 quarters
|
|
14
Union Pacific
UNP
$180B
| $8.38M | 1.19% |
39,291
+7,668
| +24% | +$1.74M |
2018 Q4
14 quarters
|
|
15
eBay
EBAY
$53.1B
| $6.96M | 0.99% |
166,929
+7,830
| +5% | +$382K |
2018 Q4
14 quarters
|
|
16
Estee Lauder
EL
$40.5B
| $6.79M | 0.97% |
26,677
+2,630
| +11% | +$667K |
2018 Q4
14 quarters
|
|
17
Danaher
DHR
$164B
| $6.57M | 0.93% |
29,247
-2,351
| -7% | -$541K |
2018 Q4
14 quarters
|
|
18
Enphase Energy
ENPH
$3.45B
| $6.22M | 0.88% |
31,845
+12,230
| +62% | +$2.21M |
2020 Q3
7 quarters
|
|
19
Colgate-Palmolive
CL
$79.2B
| $5.9M | 0.84% |
73,612
+13,908
| +23% | +$1.09M |
2019 Q1
13 quarters
|
|
20
Intuitive Surgical
ISRG
$154B
| $5.62M | 0.8% |
28,005
+6,957
| +33% | +$1.63M |
2019 Q1
13 quarters
|
|
21
Salesforce
CRM
$179B
| $4.98M | 0.71% |
30,178
+14,842
| +97% | +$2.62M |
2018 Q4
14 quarters
|
|
22
Roper Technologies
ROP
$47.5B
| $4.71M | 0.67% |
11,938
+229
| +2% | +$100K |
2022 Q1
1 quarter
|
|
23
Tesla
TSLA
$1.54T
| $4.35M | 0.62% |
19,398
+5,379
| +38% | +$1.47M |
2020 Q3
7 quarters
|
|
24
Bright Horizons
BFAM
$2.53B
| $4.33M | 0.62% |
51,275
+8,824
| +21% | +$877K |
2019 Q1
13 quarters
|
|
25
Stryker
SYK
$118B
| $4.21M | 0.6% |
21,187
+2,470
| +13% | +$580K |
2019 Q1
13 quarters
|
|
Similar funds
Mirova's Q2 2022 Portfolio in Review
As of Q2 2022, Mirova held 214 positions worth $704M, down 5.8% from $747M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Mirova deployed $68.9M of net new capital in Q2 2022, opening 40 new positions and adding to 86 existing holdings. Its largest new stake was S&P Global: 7,556 shares worth $2.55M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Materials.
On the sell side, the largest reduction was Charles Schwab, an estimated $1.42M trimmed.
- Mirova's largest Q2 2022 buy was S&P Global: 7,556 shares worth $2.55M.
- Mirova added most to AGCO in Q2 2022, an estimated $4.87M increase.
- Mirova's biggest Q2 2022 reduction was Charles Schwab, cutting an estimated $1.42M.
- Mirova fully exited Cisco in Q2 2022, selling an estimated $1.84M.
- Mirova's ten largest holdings make up 60% of its $704M portfolio in Q2 2022.
- Mirova opened 40 new positions and closed 43 in Q2 2022.
- Mirova's portfolio value fell 5.8% quarter-over-quarter to $704M.
Based on Mirova's 13F filing for Q2 2022, filed 12 Aug 2022.